Mónica V. Estrada

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

Francesca Finotello, Clemens Mayer, Christina Plattner et al. · Genome Medicine · 2019 · 1.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Brian D. Lehmann, Bojana Jovanović, Xi Chen et al. · PLoS ONE · 2016 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +17

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko et al. · Cell Metabolism · 2017 · 646 citations · Full text

Medicine, Cell Biology, Oncology +12

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado et al. · Nature Communications · 2016 · 572 citations · Full text

Life Sciences, Immunology, Oncology +17

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

Sherene Loi, Sathana Dushyanthen, Paul A. Beavis et al. · Clinical Cancer Research · 2015 · 552 citations · Full text

Medicine, Immunology, Oncology +17